Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Virtual screening in structure-based drug discovery.

X Barril1, R E Hubbard, S D Morley

  • 1Vernalis (R & D) Granta Park, Cambridge, UK. x.barril@vernalis.com

Mini Reviews in Medicinal Chemistry
|September 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using kidney transplantation to explore epigenetic markers of frailty.

GeroScience·2026
Same author

Important outcomes for patients with frailty admitted to hospital with peripheral arterial disease, their caregivers and their health professionals: A Nominal Group Technique study.

Geriatric nursing (New York, N.Y.)·2026
Same author

Frailty in younger adults in hospital.

QJM : monthly journal of the Association of Physicians·2023
Same author

Study protocol for The GOAL Trial: comprehensive geriatric assessment for frail older people with chronic kidney disease to increase attainment of patient-identified goals-a cluster randomised controlled trial.

Trials·2023
Same author

How frail is frail? A systematic scoping review and synthesis of high impact studies.

BMC geriatrics·2021
Same author

Frailty: A cost incurred by reproduction?

Scientific reports·2020
Same journal

PROTAC-Mediated Targeting of PARP via CRBN: Mechanistic Insights, Resistance Challenges, and Therapeutic Advancements.

Mini reviews in medicinal chemistry·2026
Same journal

Recent Advancements in the Development of Heterocyclic Scaffolds as Potential Anti-cancer Agents Targeting EGFR and VEGFR-2.

Mini reviews in medicinal chemistry·2026
Same journal

Exploring the Anticancer Potential of Synthetic β-Carboline Derivatives: A Comprehensive Systematic Review.

Mini reviews in medicinal chemistry·2026
Same journal

KIF20A in Human Malignancies: Oncogenic Mechanisms and Therapeutic Targeting Strategies.

Mini reviews in medicinal chemistry·2026
Same journal

Phytocompound-loaded Biomaterial-based Scaffolds: Emerging Strategies for Wound Healing Applications.

Mini reviews in medicinal chemistry·2026
Same journal

Bioprospecting of Natural Products as Sources of New Multitarget Therapies.

Mini reviews in medicinal chemistry·2026
See all related articles

Structure-based virtual screening leverages advanced computational methods for drug discovery. This review covers recent progress, validation, and applications, including Hsp90 target identification for oncology.

Area of Science:

  • Computational chemistry
  • Structural biology
  • Drug discovery

Background:

  • Advances in protein structure determination and computational techniques have propelled structure-based virtual screening (SBVS).
  • SBVS is a powerful approach for identifying novel drug candidates by computationally screening large compound libraries against a target protein structure.

Purpose of the Study:

  • To survey the progress and review recent advancements in structure-based virtual screening.
  • To discuss validation experiments and real-world applications of SBVS.
  • To provide insights into the future impact of SBVS in drug discovery.

Main Methods:

  • Review of recent literature and methodologies in SBVS.
  • Analysis of validation studies demonstrating the efficacy of SBVS.

Related Experiment Videos

  • Case study of in-house hit identification for the oncology target Heat Shock Protein 90 (Hsp90).

    • Main Results:

    • SBVS has demonstrated significant progress, with increasingly sophisticated methods and successful applications.
    • Validation experiments confirm the reliability and efficiency of SBVS in identifying potential drug leads.
    • Successful hit identification for the Hsp90 oncology target using an in-house SBVS approach.

    Conclusions:

    • Structure-based virtual screening is a mature and impactful technology in modern drug discovery.
    • Continued development in computational power and algorithms will further enhance SBVS capabilities.
    • SBVS is expected to play an increasingly vital role in accelerating the identification of novel therapeutics for various diseases.